Skip to main content
PACB
NASDAQ Life Sciences

PacBio Beats Q1 Loss Estimates as Consumable Revenue Hits Record

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.55
Mkt Cap
$498.297M
52W Low
$0.851
52W High
$2.73
52W Position info
82% above low
Off High info
43% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

PACB sits 82% above its 52-week low of $0.851.

Summary

Pacific Biosciences reported a narrower-than-expected adjusted net loss of $35.9 million for Q1, significantly beating analyst consensus of $44.68 million, with adjusted EPS also surpassing estimates. This positive financial performance comes despite flat year-over-year revenue of $37.2 million, driven by record consumable revenue but offset by weaker-than-expected instrument sales, particularly for its Vega system. The company maintains its full-year 2026 revenue guidance of $165 million to $175 million and plans a broad commercial rollout of its SPRQ-Nx chemistry, anticipating continued growth from increasing clinical adoption of its HiFi technology. This narrowing loss is a notable improvement following the significant net loss reported in 2025, indicating progress in its operational pivot.

At the time of this announcement, PACB was trading at $1.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $498.3M. The 52-week trading range was $0.85 to $2.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 10, 2026, 4:05 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.25
Real-time Price: $1.65 info
Change: -$0.599 (-27%) info
Market Cap: $510.071M info
PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $1.65 info
Change: -$0.890 (-35%) info
Market Cap: $510.071M info
PACB
Nov 04, 2026, 5:41 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $1.65 info
Change: -$0.950 (-37%) info
Market Cap: $510.071M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.65 info
Change: -$1.03 (-38%) info
Market Cap: $510.071M info
PACB
Nov 04, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $1.65 info
Change: -$0.920 (-36%) info
Market Cap: $510.071M info